Q&A With Sullivan & Cromwell's Keith Pagnani

Law360, New York (June 26, 2012, 1:53 PM EDT) -- Keith Pagnani is a partner in Sullivan & Cromwell LLP's New York office. He is co-head of the firm’s health care and life sciences group and is a member of the firm’s managing partners billing policy and diversity committees. He advises domestic and international clients in M&A transactions across various sectors, including pharmaceuticals, biotech and life sciences, medical devices, medical information systems and technologies, health providers, insurance and managed care. Recent representations include Alcon-Novartis ($50 billion), Valeant-Cephalon bid ($5.7 billion), ZOLL-Asahi Kasei ($2.21 billion), Medica HealthCare-United...
To view the full article, register now.